KUHES Programme Lead Professor Adamson Muula told Zodiak on Friday that this collaboration will spearhead research and have cannabis health products to treat cancer, epilepsy and many more diseases.

“The university’s interest is to see to it that Malawi benefits from cannabis to prevent disease and improve human wellbeing,” explained Professor Muula.

MIG Chief Executive Officer, Shoham Vigiser, said their main objective is to build a new industry to assist patients with affordable cannabis treatment and develop Malawi.

“We are happy to announce a collaboration with Kamuzu University of Health Sciences. Our objective is first of all to bring medical treatment with cannabis-based products into Malawi so as to build a new industry to help the people. Cannabis treatment is important as it can also assist Malawi to have more forex and reduce imports,” he said.

Meanwhile, a cancer survivor and director of Cancer Survivor Quest, Chikhulupiriro Junior Ng’ombe has asked the government and all regulatory bodies to give cannabis a chance in order to fight various diseases, mainly cancer.

“The benefits are enormous. I as a cancer survivor have had to spend huge sums of money, my parents spent a lot on me.  If cannabis treatment can come, the future can be saved,” said Ng’ombe.

Reports indicate that Israel has 120, 000 patients who are currently accessing cannabis products to treat cancer, epilepsy and others.